RecruitingNot ApplicableNCT06250712
Hativ® ELectrocardiogram Monitoring on Patients With Suspected Arrhythmia
Sponsor
Wonju Severance Christian Hospital
Enrollment
588 participants
Start Date
Feb 22, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
HELP-A study is a single-center, randomized, controlled trial. A total of 588 patients enrolled during the 2 years of enrollment period and followed for 1 month of follow-up period. This study aims to compare diagnostic yield between continuous ECG Patch and intermittent handheld ECG in patients with arrhythmia symptoms.
Eligibility
Min Age: 19 Years
Inclusion Criteria2
- Patients who have arrhythmia symptoms but are not diagnosed on a 12-lead electrocardiogram and require additional tests.
- Patients who can use a smartphone
Exclusion Criteria2
- Patients who have cardiac implantable electronic devices(CIEDs)
- Patients who can't use handheld ECG
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEContinous ECG Patch
Using a continuous patch ECG for 1 week during 1 month
DEVICEIntermittent handheld ECG
Using a handheld ECG twice daily and when symptoms are present during 1 month
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06250712
Related Trials
Quality of Life Before and After Transcatheter Ablation in Children With Arrythmias
NCT068082047 locations
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
NCT00271180320 locations
DiamondTemp Global Registry
NCT0473501621 locations
Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
NCT007335904 locations
Cardiac REhabilitation COhort at the Medicine Campus DaVos to invEstigate Recovery
NCT070969731 location